Natural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14-3-3ε and calmodulin

Proteomics

Volumn 12, Issue 17, 2012, Pages 2641-2655

  Russo, Lilian C ^a   Asega, Amanda F ^b   Castro, Leandro M ^a   Negraes, Priscilla D ^a   Cruz, Lilian ^a   Gozzo, Fabio C ^c   Ulrich, Henning ^a   Camargo, Antonio C M ^b   Rioli, Vanessa ^b   Ferro, Emer S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Biomedicine; Calcium; Interactome; Intracellular peptides; Peptide protein interaction; Protein target

Indexed keywords

BRAIN PROTEIN; CALCIUM ION; CALMODULIN; CELL PROTEIN; PROTEIN 14 3 3; PROTEIN 14 3 3 EPSILON; THIMET OLIGOPEPTIDASE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE;

14-3-3 PROTEINS; AMINO ACID SEQUENCE; ANIMALS; BRAIN; CALCIUM; CALMODULIN; HEK293 CELLS; HUMANS; METALLOENDOPEPTIDASES; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN INTERACTION MAPS; PROTEINS; RECOMBINANT PROTEINS;

MAMMALIA;

EID: 84865563623     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200032     Document Type: Article

References (74)

1. Chautard, E., Thierry-Mieg, N., Ricard-Blum, S., Interaction networks: from protein functions to drug discovery. A review. Pathol. Biol. 2009, 57, 324-333.
2. Frohlich, F., Sejnowski, T. J., Bazhenov, M., Network bistability mediates spontaneous transitions between normal and pathological brain states. J. Neurosci. 2010, 30, 10734-10743.
3. Stumpf, M. P., Thorne, T., de Silva, E., Stewart, R. et al., Estimating the size of the human interactome. Proc. Natl. Acad. Sci. USA. 2008, 105, 6959-6964.
4. Taylor, I. W., Linding, R., Warde-Farley, D., Liu, Y. et al., Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat. Biotechnol. 2009, 27, 199-204.
5. Vidal, M., Cusick, M. E., Barabasi, A. L., Interactome networks and human disease. Cell 2011, 144, 986-998.
6. Lalle, M., Camerini, S., Cecchetti, S., Sayadi, A. et al., The interaction network of the 14-3-3 protein in the ancient protozoan parasite Giardia duodenalis. J. Proteome. Res. 2012, 11, 2666-2683.
7. Simonis, N., Rual, J. F., Lemmens, I., Boxus, M. et al., Host-pathogen interactome mapping for HTLV-1 and 2 retroviruses. Retrovirology 2012, 9, 26.
8. Valente, A. X., Roberts, S. B., Buck, G. A., Gao, Y., Functional organization of the yeast proteome by a yeast interactome map. Proc. Natl. Acad. Sci. USA 2009, 106, 1490-1495.
9. Adikaram, P., Beckett, D., Functional versatility of a single protein surface in two protein: protein interactions. J. Mol. Biol. 2012, 419, 223-233.
10. Aziz, M. M., Maleki, M., Rueda, L., Raza, M. et al., Prediction of biological protein-protein interactions using atom-type and amino acid properties. Proteomics 2011, 11, 3802-3810.
11. Goel, A., Li, S. S., Wilkins, M. R., Four-dimensional visualisation and analysis of protein-protein interaction networks. Proteomics 2011, 11, 2672-2682.
12. Hite, K. C., Kalashnikova, A. A., Hansen, J. C., Coil-to-helix transitions in intrinsically disordered methyl CpG binding protein 2 and its isolated domains. Protein Sci. 2012, 21, 531-538.
13. Krueger, S., Shin, J. H., Raghunandan, S., Curtis, J. E. et al., Atomistic ensemble modeling and small-angle neutron scattering of intrinsically disordered protein complexes: applied to minichromosome maintenance protein. Biophys. J. 2011, 101, 2999-3007.
14. Pawson, T., Nash, P., Assembly of cell regulatory systems through protein interaction domains. Science 2003, 300, 445-452.
15. Brent, R., Bruck, J., computing: can computers help to explain biology? Nature 2006, 440, 416-417.
16. Colas, P., Cohen, B., Ko Ferrigno, P., Silver, P. A. et al., Targeted modification and transportation of cellular proteins. Proc. Natl. Acad. Sci. USA 2000, 97, 13720-13725.
17. Watt, P. M., Screening for peptide drugs from the natural repertoire of biodiverse protein folds. Nat. Biotechnol. 2006, 24, 177-183.
18. Rosenmund, C., Carr, D. W., Bergeson, S. E., Nilaver, G. et al., Anchoring of protein kinase A is required for modulation of AMPA/kainate receptors on hippocampal neurons. Nature 1994, 368, 853-856.
19. Kaneto, H., Nakatani, Y., Miyatsuka, T., Kawamori, D. et al., Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat. Med. 2004, 10, 1128-1132.
20. Stebbins, J. L., De, S. K., Machleidt, T., Becattini, B. et al., Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proc. Natl. Acad. Sci. USA 2008, 105, 16809-16813.
21. Kheifets, V., Bright, R., Inagaki, K., Schechtman, D. et al., Protein kinase C delta (deltaPKC)-annexin V interaction: a required step in deltaPKC translocation and function. J. Biol. Chem. 2006, 281, 23218-23226.
22. Ferreira, J. C., Boer, B. N., Grinberg, M., Brum, P. C. et al., Protein quality control disruption by PKCbetaII in heart failure; rescue by the selective PKCetaII inhibitor, betaIIV5-3. PLoS One 2012, 7, e33175.
23. Li, G. R., He, L. Y., Liu, X. Y., Liu, A. P. et al., Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Chem. Biol. Drug Des. 2011, 78, 835-843.
24. Sun, L., Ferreira, J. C., Mochly-Rosen, D., ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance. Sci. Transl. Med. 2011, 3, 107ra111.
25. Castro, L. M., Berti, D. A., Russo, L. C., Coelho, V. et al., Similar intracellular peptide profile of TAP1/beta2 microglobulin double-knockout mice and C57BL/6 wild-type mice as revealed by peptidomic analysis. AAPS J. 2010, 12, 608-616.
26. Fricker, L. D., Gelman, J. S., Castro, L. M., Gozzo, F. C. et al., Peptidomic analysis of HEK293T cells: effect of the proteasome inhibitor epoxomicin on intracellular peptides. J. Proteome Res. 2012, 11, 1981-1990.
27. Gelman, J. S., Sironi, J., Castro, L. M., Ferro, E. S. et al., Peptidomic analysis of human cell lines. J. Proteome Res. 2011, 10, 1583-1592.
28. Rioli, V., Gozzo, F. C., Heimann, A. S., Linardi, A. et al., Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme. J. Biol. Chem. 2003, 278, 8547-8555.
29. Gomes, I., Dale, C. S., Casten, K., Geigner, M. A. et al., Hemoglobin-derived peptides as novel type of bioactive signaling molecules. AAPS J. 2010, 12, 658-669.
30. Gomes, I., Grushko, J. S., Golebiewska, U., Hoogendoorn, S. et al., Novel endogenous peptide agonists of cannabinoid receptors. FASEB J. 2009, 23, 3020-3029.
31. Heimann, A. S., Gomes, I., Dale, C. S., Pagano, R. L. et al., Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proc. Natl. Acad. Sci. USA 2007, 104, 20588-20593.
32. Ferro, E. S., Hyslop, S., Camargo, A. C., Intracellullar peptides as putative natural regulators of protein interactions. J. Neurochem. 2004, 91, 769-777.
33. Cunha, F. M., Berti, D. A., Ferreira, Z. S., Klitzke, C. F. et al., Intracellular peptides as natural regulators of cell signaling. J. Biol. Chem. 2008, 283, 24448-24459.
34. Berti, D. A., Morano, C., Russo, L. C., Castro, L. M. et al., Analysis of intracellular substrates and products of thimet oligopeptidase in human embryonic kidney 293 cells. J. Biol. Chem. 2009, 284, 14105-14116.
35. Haynes, C. M., Yang, Y., Blais, S. P., Neubert, T. A. et al., The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. Mol. Cell 2010, 37, 529-540.
36. Kondo, T., Plaza, S., Zanet, J., Benrabah, E. et al., Small peptides switch the transcriptional activity of Shavenbaby during Drosophila embryogenesis. Science 2010, 329, 336-339.
37. Buijs, J., Franklin, G. C., SPR-MS in functional proteomics. Brief Funct. Genomic Proteomic 2005, 4, 39-47.
38. Franklin, G., McWhirter, A., in: Kambhampati, D. (Ed.), Protein Microarray Technology, Wiley-VCH, Weinheim 1994, pp. 57-106.
39. Carreno, F. R., Goni, C. N., Castro, L. M., Ferro, E. S., 14-3-3 epsilon modulates the stimulated secretion of endopeptidase 24.15. J. Neurochem. 2005, 93, 10-25.
40. Russo, L. C., Goni, C. N., Castro, L. M., Asega, A. F. et al., Interaction with calmodulin is important for the secretion of thimet oligopeptidase following stimulation. FEBS J. 2009, 276, 4358-4371.
41. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
42. Pattnaik, P., Surface plasmon resonance: applications in understanding receptor-ligand interaction. Appl. Biochem. Biotechnol. 2005, 126, 79-92.
43. Jordan, B. A., Gomes, I., Rios, C., Filipovska, J. et al., Functional interactions between mu opioid and alpha 2A-adrenergic receptors. Mol. Pharmacol. 2003, 64, 1317-1324.
44. Rios, C., Gomes, I., Devi, L. A., mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br. J. Pharmacol. 2006, 148, 387-395.
45. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
46. Martins, A. H., Alves, J. M., Trujillo, C. A., Schwindt, T. T. et al., Kinin-B2 receptor expression and activity during differentiation of embryonic rat neurospheres. Cytometry A. 2008, 73, 361-368.
47. Che, F. Y., Lim, J., Pan, H., Biswas, R. et al., Quantitative neuropeptidomics of microwave-irradiated mouse brain and pituitary. Mol. Cell Proteomics 2005, 4, 1391-1405.
48. Che, F. Y., Zhang, X., Berezniuk, I., Callaway, M. et al., Optimization of neuropeptide extraction from the mouse hypothalamus. J. Proteome Res. 2007, 6, 4667-4676.
49. Morano, C., Zhang, X., Fricker, L. D., Multiple isotopic labels for quantitative mass spectrometry. Anal. Chem. 2008, 80, 9298-9309.
50. Gillen, C. M., Forbush, B., 3rd, Functional interaction of the K-Cl cotransporter (KCC1) with the Na-K-Cl cotransporter in HEK-293 cells. Am. J. Physiol. 1999, 276, C328-C336.
51. Heimann, A. S., Favarato, M. H., Gozzo, F. C., Rioli, V. et al., ACE gene titration in mice uncovers a new mechanism for ACE on the control of body weight. Physiol. Genomics 2005, 20, 173-182.
52. Machado, M. F., Cunha, F. M., Berti, D. A., Heimann, A. S. et al., Substrate phosphorylation affects degradation and interaction to endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme. Biochem. Biophys. Res. Commun. 2006, 339, 520-525.
53. de Castro, E., Sigrist, C. J., Gattiker, A., Bulliard, V. et al., ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucleic Acids Res. 2006, 34, W362-W365.
54. Neduva, V., Russell, R. B., Peptides mediating interaction networks: new leads at last. Curr. Opin. Biotechnol. 2006, 17, 465-471.
55. Petsalaki, E., Russell, R. B., Peptide-mediated interactions in biological systems: new discoveries and applications. Curr. Opin. Biotechnol. 2008, 19, 344-350.
56. Springer, S., Doring, K., Skipper, J. C., Townsend, A. R. et al., Fast association rates suggest a conformational change in the MHC class I molecule H-2Db upon peptide binding. Biochemistry 1998, 37, 3001-3012.
57. Stanfield, R. L., Wilson, I. A., Protein-peptide interactions. Curr. Opin. Struct. Biol. 1995, 5, 103-113.
58. Stein, A., Aloy, P., Contextual specificity in peptide-mediated protein interactions. PLoS One 2008, 3, e2524.
59. Stern, L. J., Wiley, D. C., The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide. Cell 1992, 68, 465-477.
60. London, N., Movshovitz-Attias, D., Schueler-Furman, O., The structural basis of peptide-protein binding strategies. Structure, 18, 188-199.
61. Sood, V. D., Baker, D., Recapitulation and design of protein binding peptide structures and sequences. J. Mol. Biol. 2006, 357, 917-927.
62. Berti, D. A., Russo, L. C., Castro, L. M., Cruz, L. et al., Identification of intracellular peptides in rat adipose tissue: insights into insulin resistance. Proteomics 2012, DOI 10.1002/pmic.201200051.
63. Couve, A., Kittler, J. T., Uren, J. M., Calver, A. R. et al., Association of GABA(B) receptors and members of the 14-3-3 family of signaling proteins. Mol. Cell Neurosci. 2001, 17, 317-328.
64. Moore, B. W., Perez, V. J., Physiological and Biochemical Aspects of Nervous Integration, Prentice Hall, Englewood Cliffs 1967.
65. Morgan, A., Burgoyne, R. D., Interaction between protein kinase C and Exo1 (14-3-3 protein) and its relevance to exocytosis in permeabilized adrenal chromaffin cells. Biochem. J. 1992, 286(Pt 3), 807-811.
66. Tzivion, G., Avruch, J., 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J. Biol. Chem. 2002, 277, 3061-3064.
67. Smith, A. J., Daut, J., Schwappach, B., Membrane proteins as 14-3-3 clients in functional regulation and intracellular transport. Physiology 2011, 26, 181-191.
68. Henriksson, M. L., Sundin, C., Jansson, A. L., Forsberg, A. et al., Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo. Biochem. J. 2002, 367, 617-628.
69. Barbato, G., Ikura, M., Kay, L. E., Pastor, R. W. et al., Backbone dynamics of calmodulin studied by 15N relaxation using inverse detected two-dimensional NMR spectroscopy: the central helix is flexible. Biochemistry 1992, 31, 5269-5278.
70. Oliveira, V., Garrido, P. A., Rodrigues, C. C., Colquhoun, A. et al., Calcium modulates endopeptidase 24.15 (EC 3.4.24.15) membrane association, secondary structure and substrate specificity. FEBS J. 2005, 272, 2978-2992.
71. Berridge, M. J., Lipp, P., Bootman, M. D., The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 2000, 1, 11-21.
72. Goh, K. I., Cusick, M. E., Valle, D., Childs, B. et al., The human disease network. Proc. Natl. Acad. Sci. USA 2007, 104, 8685-8690.
73. Costa-Junior, H. M., Suetsugu, M. J., Krieger, J. E., Schechtman, D., Specific modulation of protein kinase activity via small peptides. Regul. Pept. 2009, 153, 11-18.
74. Joliot, A., Prochiantz, A., Transduction peptides: from technology to physiology. Nat. Cell Biol. 2004, 6, 189-196.